Breaking News

South Africa To Lead Africa, Begins Covid-19 Trails

Select Language

Advertisements

Novavax NVAX, +9.92% said it’s beginning a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, its COVID-19 vaccine candidate. The Bill & Melinda Gates Foundation providing $15 million grant toward trial, said Novavax, which last week agreed to sell its vaccine to the U.K. government if successful. “Because South Africa is experiencing a winter surge of COVID-19 disease, this important Phase 2b clinical trial has the potential to provide an early indication of efficacy, along with additional safety and immunogenicity data for NVX-CoV2373,” said Gregory Glenn, president of research and development at Novavax.

NGstudents Team Cares….. 

About Amakvitaa (8342 Articles)
Publisher, Freelance Blogger, Author, Web Developer, Machine Learning Expert And Data Scientist (C++, Python, HTML, CSS, JS, SQL)

Say Something !! (Comment)

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: